RS51855B - Mikrobiološki postupak za dobijanje 7alfa-supstituisanih 11alfa-hidroksisteroida - Google Patents

Mikrobiološki postupak za dobijanje 7alfa-supstituisanih 11alfa-hidroksisteroida

Info

Publication number
RS51855B
RS51855B YU20050045A YUP4505A RS51855B RS 51855 B RS51855 B RS 51855B YU 20050045 A YU20050045 A YU 20050045A YU P4505 A YUP4505 A YU P4505A RS 51855 B RS51855 B RS 51855B
Authority
RS
Serbia
Prior art keywords
substituted
stands
hydroxysteroids
7alpha
general formula
Prior art date
Application number
YU20050045A
Other languages
English (en)
Serbian (sr)
Inventor
Rolf Bohlmann
Hermann Künzer
Reinhard Nubbemeyer
Hans-Peter Muhn
Ludwig Zorn
Norbert Gallus
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/de
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of RS20050045A publication Critical patent/RS20050045A/sr
Publication of RS51855B publication Critical patent/RS51855B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
YU20050045A 2002-07-24 2003-07-24 Mikrobiološki postupak za dobijanje 7alfa-supstituisanih 11alfa-hidroksisteroida RS51855B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (de) 2002-07-24 2002-07-24 Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US40295302P 2002-08-14 2002-08-14
PCT/EP2003/008111 WO2004011663A2 (de) 2002-07-24 2003-07-24 Mikrobiologische verfahren zur herstellung von 7alpha-substituierten 11alpha-hydroxysteroiden

Publications (2)

Publication Number Publication Date
RS20050045A RS20050045A (en) 2007-06-04
RS51855B true RS51855B (sr) 2012-02-29

Family

ID=31189296

Family Applications (1)

Application Number Title Priority Date Filing Date
YU20050045A RS51855B (sr) 2002-07-24 2003-07-24 Mikrobiološki postupak za dobijanje 7alfa-supstituisanih 11alfa-hidroksisteroida

Country Status (20)

Country Link
EP (1) EP1523568A2 (pt)
JP (1) JP4417838B2 (pt)
KR (1) KR101041328B1 (pt)
CN (1) CN100339486C (pt)
BR (1) BR0313210A (pt)
CA (1) CA2492079C (pt)
CO (1) CO5690563A2 (pt)
CR (1) CR7672A (pt)
EA (2) EA010572B1 (pt)
EC (1) ECSP055630A (pt)
HK (1) HK1081999A1 (pt)
HR (1) HRP20050172A2 (pt)
IL (1) IL166358A0 (pt)
MX (1) MXPA05001024A (pt)
NO (1) NO20050980L (pt)
NZ (2) NZ549529A (pt)
PH (1) PH12005500143B1 (pt)
PL (1) PL373808A1 (pt)
RS (1) RS51855B (pt)
WO (1) WO2004011663A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101296936B (zh) * 2005-10-27 2011-06-22 大鹏药品工业株式会社 生产甾族化合物的方法
CN103834712B (zh) * 2012-11-26 2016-03-30 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75841C (pt) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) * 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) * 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) * 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167381A3 (en) * 1995-12-11 2004-09-29 G.D. Searle & Co. Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
CN1138861C (zh) * 1995-12-12 2004-02-18 阿克佐诺贝尔公司 类固醇的微生物11α-羟基化方法
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
SI1267885T1 (sl) 2000-02-15 2007-08-31 Bayer Schering Pharma Ag Formulacija za moško kontracepcijo, ki vsebuje noretisteron in testosteron undekanoat
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
ES2299735T3 (es) * 2002-07-25 2008-06-01 Bayer Schering Pharma Aktiengesellschaft Composicion, que contiene un 11-beta-halogeno-esteroide androgeno y un gestageno, asi como un anticonceptivo masculino sobre la base de esta composicion.

Also Published As

Publication number Publication date
RS20050045A (en) 2007-06-04
EA200601030A1 (ru) 2006-10-27
PL373808A1 (en) 2005-09-19
CO5690563A2 (es) 2006-10-31
EA200500224A1 (ru) 2005-08-25
CN100339486C (zh) 2007-09-26
CA2492079A1 (en) 2004-02-05
PH12005500143B1 (en) 2011-03-25
EA008147B1 (ru) 2007-04-27
BR0313210A (pt) 2005-06-28
NO20050980L (no) 2005-02-23
JP2006503813A (ja) 2006-02-02
JP4417838B2 (ja) 2010-02-17
MX260952B (pt) 2008-10-01
EP1523568A2 (de) 2005-04-20
KR101041328B1 (ko) 2011-06-14
AU2003281677A1 (en) 2004-02-16
MXPA05001024A (es) 2005-05-16
HK1081999A1 (en) 2006-05-26
KR20050026507A (ko) 2005-03-15
IL166358A0 (en) 2006-01-16
NZ549529A (en) 2008-04-30
CA2492079C (en) 2012-01-10
ECSP055630A (es) 2005-04-18
CN1671858A (zh) 2005-09-21
WO2004011663A9 (de) 2004-05-06
WO2004011663A3 (de) 2004-07-15
WO2004011663A2 (de) 2004-02-05
HRP20050172A2 (en) 2005-04-30
EA010572B1 (ru) 2008-10-30
CR7672A (es) 2006-05-29
NZ537871A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
ATE203015T1 (de) Pyrazol-derivate, verfahren für ihre herstellung und sie enthaltende zusammensetzungen
EA200601822A1 (ru) Способы получения полиморфной формы i гидросульфата клопидогрела
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
MX2010002692A (es) Sintesis de catecoles deuterados y derivados de benzo[d][1,3]dioxoles de los mismos.
HUP0300567A2 (hu) Eljárás új piperazinszármazékok elżállítására
EA200900817A1 (ru) Способ получения фторметилзамещённых гетероциклических соединений
EP1378505A4 (en) PROCESS FOR SYNTHESIS OF COMPOUNDS RELATED TO CAMPTOTHECIN
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
HUP0204252A2 (hu) Eljárások a clarithromycin polimorf módosulatainak előállítására és ezeket tartalmazó gyógyszerkészítmények
ATE522529T1 (de) Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst
NO20071922L (no) Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler
RS20070095A (en) Alkyliden-tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
RS51855B (sr) Mikrobiološki postupak za dobijanje 7alfa-supstituisanih 11alfa-hidroksisteroida
TNSN03117A1 (en) Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
MXPA06002919A (es) Sustancias colorantes azoicas dispersas.
ATE193297T1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
MY152878A (en) Novel cosmetic cream composition comprising c12-c20 fatty acid
MX2009005782A (es) Derivados de pirano, procedimiento de preparacion y uso de los mismos en perfumeria y saborizantes.
DE502004002035D1 (de) Acetale, ihre verwendung als riechstoffe und verfahren zu ihrer herstellung
TW200518778A (en) Shampoo composition
DK1615651T3 (da) Fremgangsmåde til fremstilling af ferutinin fra Ferula plantefamilier
HUP0300504A2 (hu) 21,16alfa-laktongyűrűs 19-nor-17alfa-pregna-1,3,5(10)-trién-17béta-olok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HK1144822A1 (pt)